ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss (redOrbit) Print E-mail

More info...
SAN CLEMENTE, Calif., March 3 /PRNewswire/ -- ReShape Medical(TM), Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss.